Credit Agricole
INSY

Credit Agricole’s Insys Therapeutics, Inc. INSY Stock Holding History

Credit Agricole’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-182,400
Closed -$2.31M – 1473
2017
Q2 		$2.31M Sell
182,400
-192,000
-51% -$2.27M 0.01% 890
2017
Q1 		$3.94M Buy
374,400
+62,400
+20% +$665K 0.01% 811
2016
Q4 		$2.87M Buy
312,000
+120,000
+63% +$1.36M 0.01% 842
2016
Q3 		$2.26M Hold
192,000
– – 0.01% 914
2016
Q2 		$2.48M Hold
192,000
– – 0.01% 790
2016
Q1 		$3.07M Buy
192,000
+167,634
+688% +$3.18M 0.01% 674
2015
Q4 		$698K Sell
24,366
-1,800
-7% -$49.9K ﹤0.01% 1104
2015
Q3 		$745K Buy
26,166
+2,450
+10% +$90.2K ﹤0.01% 1072
2015
Q2 		$852K Buy
+23,716
New +$739K ﹤0.01% 1070

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Agricole's INSY Position: Q3 2017 in Review

Credit Agricole sold out of Insys Therapeutics, Inc. (INSY) in Q3 2017, closing a stake of 182,400 shares — an estimated $2.31M sold.

Credit Agricole first reported a position in INSY in Q2 2015 and held it in 9 quarters. The position peaked at $3.94M in Q1 2017. 116 funds tracked by Wall St. Rank hold INSY as of Q3 2017.

  • Credit Agricole reported no remaining Insys Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Credit Agricole sold 182,400 Insys Therapeutics, Inc. shares in Q3 2017, an estimated $2.31M.
  • Credit Agricole first reported a position in Insys Therapeutics, Inc. in Q2 2015 and held it in 9 quarters.
  • Credit Agricole's Insys Therapeutics, Inc. position peaked at $3.94M in Q1 2017.
  • 116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2017.

Based on Credit Agricole's 13F filing for Q3 2017, filed 14 Nov 2017.